SGLT2 inhibition also leads to an acute reduction in SNGFR in animals [8] and lowering of global GFR in individuals with diabetes [32], akin to the acute reduction in inulin clearance reported with the SGLT1/2 inhibitor, phlorizin, in healthy non-diabetic subjects [33]. Here, SLC5A2 is linked to diabetes mellitus.